For Pfizer COVID-19 vaccine in children benefits outweigh risks - FDA

Jerusalem Post

Published

If the FDA authorizes the Pfizer/BioNTech immunization for children 5 to 11 years old, it would be the first COVID-19 vaccine for the age group.

Full Article